Evaluation of the relation of BRAF inhibitor resistance and HIF1 regulation in malignant melanoma cell lines

被引：0
|
作者：
Baskin, Yasemin [1 ]
机构：
[1] Dokuz Eylul Univ, Inst Oncol, Alsancak, Turkey
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2017年 / 76卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
5518
引用
收藏
页码：AB133 / AB133
页数：1
相关论文
共 50 条
  • [41] Salinomycin, an anti-cancer stem cell antibiotic, overcomes acquired resistance to BRAF inhibitors in BRAF-mutant human melanoma cell lines.
    Crespo, Daniel
    Pulido, Ines
    Rodriguez, Maria L.
    Aparisi, Salvador
    Lopez, Alejandro
    Soucheray, Margaret
    Al-Shahrour, Fatima
    Shimamura, Takeshi
    Ortega, Angel
    Carretero, Julian
    MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [42] Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27
    Kumar, Sanjay
    Vaidya, Meenal
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2016, 415 (1-2) : 29 - 38
  • [43] Effects of BRAF- and MEK-Inhibitor Combinations in sensitive and resistant NRAS-mutated Melanoma Cell Lines
    Schulz, A.
    Dinter, L.
    Karitzky, P. C.
    Tunger, A.
    Mueller, A.
    Kaeubler, T.
    Wehner, R.
    Niessner, H.
    Wanke, I.
    Beissert, S.
    Seliger, B.
    Schmitz, M.
    Meier, F.
    Westphal, D.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2021, 19 : 29 - 29
  • [44] Hypoxia inhibits mesenchymal stem cell proliferation through HIF1α-dependent regulation of P27
    Sanjay Kumar
    Meenal Vaidya
    Molecular and Cellular Biochemistry, 2016, 415 : 29 - 38
  • [45] High Activity of the Aurora B kinase Inhibitor AZD1152 on Melanoma Cell Lines Irrespective of BRAF Mutation
    Porcelli, L.
    Quatrale, A. E.
    Guida, G.
    Mantuano, P.
    Zanna, P.
    Strippoli, S.
    Guida, S.
    Grieco, C.
    Albano, A.
    Tommasi, S.
    Pinto, R.
    De Summa, S.
    Paradiso, A.
    Guida, M.
    Azzariti, A.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2013, 11 : 69 - 70
  • [46] BRAF inhibitor resistance of melanoma cells triggers increased susceptibility to natural killer cell-mediated lysis
    Frazao, Alexandra
    Rethacker, Louise
    Jeudy, Geraldine
    Colombo, Marina
    Pasmant, Eric
    Avril, Marie-Francoise
    Toubert, Antoine
    Moins-Teisserenc, Helene
    Roelens, Marie
    Dalac, Sophie
    Maubec, Eve
    Caignard, Anne
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 (02)
  • [47] PKM2 and HIF-1α regulation in prostate cancer cell lines
    Hasan, Diya
    Gamen, Elisabetta
    Abu Tarboush, Nafez
    Ismail, Yazan
    Pak, Oleg
    Azab, Belal
    PLOS ONE, 2018, 13 (09):
  • [48] Potent anticancer activity against both BRAF-mutant and BRAF wild-type melanoma cell lines using a novel CRM1 nuclear export inhibitor
    Fragomeni, Roberto A. Salas
    Chung, Hye-Won
    Shacham, Sharon
    Kauffman, Michael
    Cusack, James C.
    CANCER RESEARCH, 2012, 72
  • [49] Novel selective HIF1 alpha inhibitor: Well tolerated with excellent efficacy in renal cell cancer xenograft studies
    Dubey, Ramin
    Grishagin, Ivan
    Nagavarapu, Usha
    Balan, Chenera
    Gupta, Shalabh
    Olenyuk, Bogdan Z.
    CANCER RESEARCH, 2014, 74 (19)
  • [50] E2F1/IGF-1R Loop Contributes to BRAF Inhibitor Resistance in Melanoma
    Liu, Xiao
    Mi, Jun
    Qin, Haihong
    Li, Zheng
    Chai, Jingxiu
    Li, Ming
    Xu, Jinfeng
    Xu, Jinhua
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2020, 140 (06) : 1295 - +
12345